A Quiet Revolution in Clean-Energy Finance
Harvard Business Review
OCTOBER 26, 2011
Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Click on the table below to see at full size.).
10 
Let's personalize your content